Screener

Eligibility screening

Safety of Combining Irinotecan With 5-FU, Leucovorin/Folinic Acid, Oxaliplatin, and Docetaxel Chemotherapies

Sponsored by University of ChicagoStudy detailsClinicalTrials.gov

1 US site in IL

Before we begin

Who are you filling this out for?

Your answer affects how the questions are phrased.